William L. Trepicchio

Author

Millennium Engineering and Integration (United States)ORCID

Also Known As

W L Trepicchio, W Trepicchio, W. Trepicchio, W.L. Trepicchio, WILLIAM L. TREPICCHIO, WILLIAM TREPICCHIO, William L Trepicchio, William L. Trepicchio, William Trepicchio

Publications

4.8K

Citations

H-Index

Concepts

All Affiliations

Millennium Engineering and Integration (United States)Takeda (United States)Dana-Farber Cancer Institute Harvard University The University of Texas MD Anderson Cancer Center

About

William L. Trepicchio is an author at Millennium Engineering and Integration (United States) specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	1.5K
2	Engineering	2	2	227
3	Health Sciences	2	2	63
4	Allergy	2	2	68
5	Biostatistics	1	1	50

William L. Trepicchio

Publications

4.5K

Citations

H-Index

Page 1

	Year	Citations
Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris Edmund Lee, William L. Trepicchio, Judith Oestreicher, The Journal of Experimental Medicine	2004	889
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial H. Miles Prince, Youn H. Kim, Reinhard Dummer, The Lancet Hematological MalignancyLymphoid NeoplasiaMedicineClinical TrialsPathology	2017	569
Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib George Mulligan, Constantine S. Mitsiades, Barbara M. Bryant, Blood	2006	409
Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production William L. Trepicchio, M Bozza, G Pedneault, The Journal of Immunology	1996	288
Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions William L. Trepicchio, Maki Ozawa, Ian Walters, Journal of Clinical Investigation	1999	222
IL-11 regulates macrophage effector function through the inhibition of nuclear factor-kappaB William L. Trepicchio, Loretta Wang, Marcelo T. Bozza, The Journal of Immunology	1997	203
Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling Judy Oestreicher, Ian Walters, Toyoko Kikuchi, The Pharmacogenomics Journal BioinformaticsEngineeringAutoimmune DiseaseMedicineImmunology	2001	177
Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Natalie C. Twine, Jennifer A. Stover, Bonnie Marshall, PubMed Tumor BiologyNormal VolunteersGenitourinary CancerMedicineRenal Pathology	2003	152
Transcriptional Profiles in Peripheral Blood Mononuclear Cells Prognostic of Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Michael E. Burczynski, Natalie C. Twine, Gary Dukart, Clinical Cancer Research	2005	117
Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy George Mulligan, David I. Lichter, Alessandra Di Bacco, Blood	2013	115

Page 1